Business Name: |
Caballes Jr Romeo A MD |
Contact Person: |
Romeo Caballes Jr |
Address: |
633 State Route 28, Raritan, New Jersey 08869 |
Phone Number: |
(908) 526-8950 |
Annual Revenue (USD): |
$1.000.000 to $2.499.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Scully Dr - Raritan, NJ 08869 Grandhi Sankara MD - Raritan, NJ 08869 Wang Yue He MD - Raritan, NJ 08869 Office Of Amanda Kaveney Md - Raritan, NJ 08869 Parlavecchio Joseph G MD - Raritan, NJ 08869 Maldonado Samuel D MD - Raritan, NJ 08869 O'Hara Jennifer F MD - Raritan, NJ 08869 Bieler Harvey MD - Raritan, NJ 08869 Shah Ashish MD - Raritan, NJ 08869 Hait William N MD - Raritan, NJ 08869 Cody Jr Robert J MD - Raritan, NJ 08869 Jordan-Scalia Lisa J DO - Raritan, NJ 08869 Maria Elena Ocasio M D - Raritan, NJ 08869 Office Of Chandreshwar N Shahi Md - Raritan, NJ 08869 Ocasio Maria E MD - Raritan, NJ 08869 Kantha Sulliva Brinda S DO - Raritan, NJ 08869 Womens Hlth Center At Raritan Inc - Raritan, NJ 08869 Benning Kathleen M DO - Raritan, NJ 08869 Hunterdon Cardiovascular Assoc - Raritan, NJ 08869 Lawrence Ferraro Do - Raritan, NJ 08869 |
The company Caballes Jr Romeo A MD provides B2C services in the form of Doctors from its single location in New Jersey.
1 to 4 employees work for Caballes Jr Romeo A MD, and the business now earns $1.000.000 to $2.499.999 per annum.
Caballes Jr Romeo A MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Caballes Jr Romeo A MD, please call Romeo Caballes Jr with the phone number (908) 526-8950 or visit its single location at 633 State Route 28 in Raritan, New Jersey 08869.
The location of the single location can also be found using the coordinates 40.581825,-74.640213.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.